MXPA01009709A - Proceso para la preparacion de aziridinil epotilonas a partir de oxiranil epotilonas. - Google Patents
Proceso para la preparacion de aziridinil epotilonas a partir de oxiranil epotilonas.Info
- Publication number
- MXPA01009709A MXPA01009709A MXPA01009709A MXPA01009709A MXPA01009709A MX PA01009709 A MXPA01009709 A MX PA01009709A MX PA01009709 A MXPA01009709 A MX PA01009709A MX PA01009709 A MXPA01009709 A MX PA01009709A MX PA01009709 A MXPA01009709 A MX PA01009709A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- substituted
- group
- aryl
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12693699P | 1999-03-29 | 1999-03-29 | |
| PCT/US2000/007426 WO2000057874A1 (en) | 1999-03-29 | 2000-03-20 | A process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01009709A true MXPA01009709A (es) | 2002-05-14 |
Family
ID=22427457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01009709A MXPA01009709A (es) | 1999-03-29 | 2000-03-20 | Proceso para la preparacion de aziridinil epotilonas a partir de oxiranil epotilonas. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1165067A4 (hu) |
| JP (1) | JP2002540154A (hu) |
| KR (1) | KR20020005639A (hu) |
| AU (1) | AU4017400A (hu) |
| CA (1) | CA2368658A1 (hu) |
| HU (1) | HUP0200583A3 (hu) |
| IL (1) | IL144590A0 (hu) |
| MX (1) | MXPA01009709A (hu) |
| WO (1) | WO2000057874A1 (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69734362T2 (de) | 1996-12-03 | 2006-07-20 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon |
| SI1483251T1 (sl) | 2002-03-12 | 2010-03-31 | Bristol Myers Squibb Co | C cian epotilonski derivati |
| EP1674098A1 (en) * | 2004-12-23 | 2006-06-28 | Schering Aktiengesellschaft | Stable and tolerable parental formulations of highly reactive organic drug substances with low or no solubility in water |
| EP2065054A1 (en) | 2007-11-29 | 2009-06-03 | Bayer Schering Pharma Aktiengesellschaft | Combinations comprising a prostaglandin and uses thereof |
| DE102007059752A1 (de) | 2007-12-10 | 2009-06-18 | Bayer Schering Pharma Aktiengesellschaft | Funktionalisierte, feste Polymernanopartikel enthaltend Epothilone |
| EP2070521A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Surface-modified nanoparticles |
| EP2210584A1 (en) | 2009-01-27 | 2010-07-28 | Bayer Schering Pharma Aktiengesellschaft | Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer |
| JP5881254B2 (ja) | 2010-05-18 | 2016-03-09 | セルリアン・ファーマ・インコーポレイテッド | 自己免疫疾患およびその他の疾患の治療のための組成物および方法 |
| EP2793947B1 (en) | 2011-12-23 | 2021-02-03 | Innate Pharma | Enzymatic conjugation of polypeptides |
| WO2014009426A2 (en) | 2012-07-13 | 2014-01-16 | Innate Pharma | Screening of conjugated antibodies |
| EP2916872B1 (en) | 2012-11-09 | 2019-02-27 | Innate Pharma | Recognition tags for tgase-mediated conjugation |
| EP2968582B1 (en) | 2013-03-15 | 2020-07-01 | Innate Pharma | Solid phase tgase-mediated conjugation of antibodies |
| US10071169B2 (en) | 2013-06-20 | 2018-09-11 | Innate Pharma | Enzymatic conjugation of polypeptides |
| WO2014202775A1 (en) | 2013-06-21 | 2014-12-24 | Innate Pharma | Enzymatic conjugation of polypeptides |
| WO2019092148A1 (en) | 2017-11-10 | 2019-05-16 | Innate Pharma | Antibodies with functionalized glutamine residues |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT873341E (pt) * | 1995-11-17 | 2004-02-27 | Biotechnolog Forschung Mbh Gbf | Derivados de epotilona preparacao e utilizacao |
| US6380395B1 (en) * | 1998-04-21 | 2002-04-30 | Bristol-Myers Squibb Company | 12, 13-cyclopropane epothilone derivatives |
-
2000
- 2000-03-20 CA CA002368658A patent/CA2368658A1/en not_active Abandoned
- 2000-03-20 JP JP2000607625A patent/JP2002540154A/ja active Pending
- 2000-03-20 KR KR1020017012398A patent/KR20020005639A/ko not_active Application Discontinuation
- 2000-03-20 EP EP00919495A patent/EP1165067A4/en not_active Withdrawn
- 2000-03-20 HU HU0200583A patent/HUP0200583A3/hu unknown
- 2000-03-20 AU AU40174/00A patent/AU4017400A/en not_active Abandoned
- 2000-03-20 MX MXPA01009709A patent/MXPA01009709A/es unknown
- 2000-03-20 WO PCT/US2000/007426 patent/WO2000057874A1/en active Search and Examination
- 2000-03-20 IL IL14459000A patent/IL144590A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4017400A (en) | 2000-10-16 |
| HUP0200583A2 (en) | 2002-06-29 |
| EP1165067A4 (en) | 2002-06-26 |
| CA2368658A1 (en) | 2000-10-05 |
| EP1165067A1 (en) | 2002-01-02 |
| IL144590A0 (en) | 2002-05-23 |
| KR20020005639A (ko) | 2002-01-17 |
| HUP0200583A3 (en) | 2004-07-28 |
| WO2000057874A1 (en) | 2000-10-05 |
| JP2002540154A (ja) | 2002-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6291684B1 (en) | Process for the preparation of aziridinyl epothilones from oxiranyl epothilones | |
| US6262094B1 (en) | C-21 modified epothilones | |
| ES2322807T3 (es) | Derivados de epotilona. | |
| US6399638B1 (en) | 12,13-modified epothilone derivatives | |
| US6831090B2 (en) | 2,3-olefinic epothilone derivatives | |
| MXPA01009709A (es) | Proceso para la preparacion de aziridinil epotilonas a partir de oxiranil epotilonas. | |
| US6719540B2 (en) | C3-cyano epothilone derivatives | |
| US7211593B2 (en) | C12-cyano epothilone derivatives |